Allspring Global Investments’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,062
Closed -$386K 1784
2025
Q4
$386K Buy
27,062
+2,214
+9% +$21.8K ﹤0.01% 1443
2025
Q3
$192K Sell
24,848
-222
-0.9% -$1.58K ﹤0.01% 1551
2025
Q2
$146K Buy
25,070
+540
+2% +$3.48K ﹤0.01% 1568
2025
Q1
$195K Buy
24,530
+8,567
+54% +$79.3K ﹤0.01% 1659
2024
Q4
$149K Sell
15,963
-100
-0.6% -$1.04K ﹤0.01% 1695
2024
Q3
$172K Sell
16,063
-1,036
-6% -$11.3K ﹤0.01% 1706
2024
Q2
$170K Sell
17,099
-81
-0.5% -$831 ﹤0.01% 1744
2024
Q1
$202K Sell
17,180
-35,437
-67% -$453K ﹤0.01% 1700
2023
Q4
$747K Sell
52,617
-14,161
-21% -$161K ﹤0.01% 1410
2023
Q3
$812K Sell
66,778
-41,311
-38% -$533K ﹤0.01% 1411
2023
Q2
$1.36M Buy
108,089
+77,844
+257% +$924K ﹤0.01% 1339
2023
Q1
$335K Buy
30,245
+3,069
+11% +$37.8K ﹤0.01% 1687
2022
Q4
$332K Sell
27,176
-302
-1% -$3.4K ﹤0.01% 1706
2022
Q3
$286K Sell
27,478
-1,674
-6% -$18.7K ﹤0.01% 1716
2022
Q2
$313K Sell
29,152
-129,839
-82% -$1.07M ﹤0.01% 1692
2022
Q1
$1.5M Buy
158,991
+450
+0.3% +$4.22K ﹤0.01% 1654
2021
Q4
$1.83M Buy
+158,541
New +$1.77M ﹤0.01% 1588

Other funds holding FOLD

Allspring Global Investments's FOLD Position: Q1 2026 in Review

Allspring Global Investments sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 27,062 shares — an estimated $386K sold.

Allspring Global Investments first reported a position in FOLD in Q4 2021 and held it in 17 quarters. The position peaked at $1.83M in Q4 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Allspring Global Investments reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Allspring Global Investments sold 27,062 Amicus Therapeutics shares in Q1 2026, an estimated $386K.
  • Allspring Global Investments first reported a position in Amicus Therapeutics in Q4 2021 and held it in 17 quarters.
  • Allspring Global Investments's Amicus Therapeutics position peaked at $1.83M in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.